Combination of Cisplatin-Withaferin Based on PEGylated Liposome Nanoparticles as Alternative Therapy for Ovarian Cancer

Journal of Medicine and Health
doi 10.28932/jmh.v2i5.1129
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Maranatha Christian University

Related search

Hybrid Nanoparticles for Combination Therapy of Cancer

Journal of Controlled Release
Pharmaceutical Science
2015English

Nanoparticles for Effective Combination Therapy of Cancer

International Journal of Nanotechnology and Nanomedicine
2016English

Layer‐by‐Layer Nanoparticles for Novel Delivery of Cisplatin and PARP Inhibitors for Platinum‐Based Drug Resistance Therapy in Ovarian Cancer

Bioengineering & Translational Medicine
2019English

Fabrication of PEGylated Bi2S3 Nanosheets as a Multifunctional Platform for Multimodal Diagnosis and Combination Therapy for Cancer

English

Theranostic Nanoplatform: Triple-Modal Imaging-Guided Synergistic Cancer Therapy Based on Liposome-Conjugated Mesoporous Silica Nanoparticles

English

CDK4/6 Inhibition as Maintenance and Combination Therapy for High Grade Serous Ovarian Cancer

Oncotarget
Oncology
2018English

Shikonin-Loaded Antibody-Armed Nanoparticles for Targeted Therapy of Ovarian Cancer

International Journal of Nanomedicine
Organic ChemistryBiophysicsBiomaterialsPharmaceutical ScienceMedicineBioengineeringDrug DiscoveryNanoscienceNanotechnology
2014English

Telodendrimer Nanocarrier for Co-Delivery of Paclitaxel and Cisplatin: A Synergistic Combination Nanotherapy for Ovarian Cancer Treatment

Biomaterials
Mechanics of MaterialsBiophysicsBiomaterialsBioengineeringCompositesNanoscienceNanotechnologyCeramics
2015English

Tumor-Targeting, microRNA-silencing Porous Silicon Nanoparticles for Ovarian Cancer Therapy

ACS Applied Materials & Interfaces
MedicineMaterials ScienceNanotechnologyNanoscience
2019English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy